Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1989. Upgrade now.
Date Value
September 30, 2024 -9.882B
June 30, 2024 7.544B
March 31, 2024 546.00M
December 31, 2023 -4.655B
September 30, 2023 -11.32B
June 30, 2023 -5.991B
March 31, 2023 6.138B
December 31, 2022 1.70B
September 30, 2022 -3.925B
June 30, 2022 -2.261B
March 31, 2022 -4.385B
December 31, 2021 -3.436B
September 30, 2021 -2.207B
June 30, 2021 -3.279B
March 31, 2021 -5.125B
December 31, 2020 -5.644B
September 30, 2020 4.196B
June 30, 2020 -357.00M
March 31, 2020 -4.315B
December 31, 2019 -4.072B
September 30, 2019 -3.893B
June 30, 2019 -4.534B
March 31, 2019 -5.516B
December 31, 2018 -6.389B
September 30, 2018 -3.477B
Date Value
June 30, 2018 -2.674B
March 31, 2018 -5.97B
December 31, 2017 -3.537B
September 30, 2017 -2.069B
June 30, 2017 -1.917B
March 31, 2017 -150.00M
December 31, 2016 -3.464B
September 30, 2016 -3.445B
June 30, 2016 -1.038B
March 31, 2016 -604.00M
December 31, 2015 -3.294B
September 30, 2015 -1.84B
June 30, 2015 -2.775B
March 31, 2015 -3.227B
December 31, 2014 -858.00M
September 30, 2014 -5.716B
June 30, 2014 -2.868B
March 31, 2014 -3.057B
December 31, 2013 1.182B
September 30, 2013 -4.519B
June 30, 2013 -1.977B
March 31, 2013 -777.00M
December 31, 2012 -1.471B
September 30, 2012 -1.653B
June 30, 2012 -16.26B

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-11.32B
Minimum
Sep 2023
7.544B
Maximum
Jun 2024
-2.536B
Average
-3.680B
Median

Cash from Financing (Quarterly) Benchmarks

Amgen Inc -3.651B
Eli Lilly and Co 211.30M
Merck & Co Inc -2.425B
Pfizer Inc -4.636B
AbbVie Inc -3.072B